Advancis initiates phase III trial for sore throat treatment
14th Nov 2005, 12:47 GMT
Advancis Pharmaceutical has begun enrollment in its phase III clinical trial for Amoxicillin Pulsys for adults and adolescents with pharyngitis and tonsillitis.
Advancis initiates phase III trial for sore throat treatment related news:
- TorreyPines Therapeutics Initiates Phase I Clinical Trial for NGX424, a 1st-in-Class Compound for Severe Pain — Cardiology News from StratCenter.com
- TorreyPines initiates early trial of severe pain drug — Pharmaceutical Business Review Online
- Too many kids being prescribed antibiotics for sore throat — Medical News Today RSS/XML Feed
- Inhibitex Reports Completion of Enrollment in Pivotal Phase III Clinical Trial of Veronate — Intensive/ Critical Care News from StratCenter.com
- Xenome initiates cancer pain trial — Pharmaceutical Business Review Online
- Positive phase I trial for Schering-Plough HCV treatment — Pharmaceutical Business Review Online
- Study: Kids' Sore Throats Misdiagnosed — RedOrbit News - Health
- GSK says new data back malaria treatment (Reuters) — Yahoo! News: Health News
- Positive late-stage trial for Shire ADHD patch — Pharmaceutical Business Review Online
- Synairgen to test asthma treatment — Pharmaceutical Business Review Online
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol